• Earlier this week, Agilent Technologies reported third-quarter 2026 results showing sales of US$1,878 million and net income of US$362 million, with earnings per share from continuing operations rising to US$1.28 from US$1.18 a year ago.
• The company also raised its full-year 2026 revenue and profit guidance, citing stronger demand in pharma, China, and advanced materials, plus margin benefits from its Ignite efficiency program and new product launches.
• Next, we’ll examine how the upgraded full-year 2026 guidance may reshape Agilent’s investment narrative built around efficiency and innovation.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Agilent Technologies Investment Narrative Recap

To own Agilent, you need to believe in its ability to convert pharma, China and advanced materials demand into profitable, recurring revenue while keeping tariffs and supply chain costs in check. The latest earnings beat and higher 2026 guidance support the near term catalyst around Ignite-driven margin gains, while tariff and input cost volatility remains the most important risk to watch. Overall, the Q3 update reinforces the existing story rather than changing it.

The most relevant development here is Agilent’s raised full year 2026 revenue outlook to US$7.49 billion to US$7.51 billion, alongside upgraded profit guidance. This directly ties into the efficiency and innovation catalyst, suggesting Ignite and recent product launches are helping offset cost pressures and support core demand in pharma and advanced materials. For investors, it connects the headline results to the underlying execution needed for the thesis to keep working over time.

Yet even with improved guidance, the ongoing tariff and supply chain pressures are something investors should be aware of as...

Agilent Technologies' narrative projects $8.8 billion revenue and $2.1 billion earnings by 2029. This requires 6.7% yearly revenue growth and a roughly $0.7 billion earnings increase from $1.4 billion today.

Uncover how Agilent Technologies' forecasts yield a $161.00 fair value, a 5% upside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community cluster between US$150.54 and about US$192.91, underscoring how differently individual investors assess Agilent’s prospects. Set against the raised 2026 guidance tied to Ignite efficiencies, this spread invites you to weigh how much those margin and product cycle catalysts might matter for the company’s longer term performance.

Explore 4 other fair value estimates on Agilent Technologies - why the stock might be worth as much as 25% more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Agilent Technologies research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free Agilent Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Agilent Technologies' overall financial health at a glance.

Want Some Alternatives?

Our top stock finds are flying under the radar-for now. Get in early:

• Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.
• The future of work is here. Discover the 38 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.